Reference priceJPY ¥770.00Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Iqirvo |
|---|---|
| Manufacturer | IPSEN PHARMA S.A. |
| Prescription required | Yes |
Iqirvo tablets 30 x 80mg(Elafibranor)
Elafibranor
Description
Iqirvo tablets 30 x 80mg(Elafibranor) is a medicine catalog record in the MediPriceHub database. Active ingredient: Elafibranor. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: IPSEN PHARMA S.A.. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Pack information: 80 / 30. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
IQIRVO is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA. This indication is approved under accelerated approval based on reduction of alkaline phosphatase (ALP) [see Clinical Studies ] . Improvement in survival or prevention of liver decompensation events have not been demonstrated. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).How to Use
Use Elafibranor under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: Elafibranor. Pack size: 80 / 30. Pack unit: bottle. Manufacturer: IPSEN PHARMA S.A.. Origin country: United States. Source category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.この情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。